These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 24338761)
21. Jia X; Shao L; Liu C; Chen T; Peng L; Cao Y; Zhang C; Yang X; Zhang G; Gao J; Fan G; Gu M; Du H; Xia Z Aging (Albany NY); 2020 Mar; 12(5):4268-4282. PubMed ID: 32126021 [TBL] [Abstract][Full Text] [Related]
22. Two new missense mutations of GAA in late onset glycogen storage disease type II. Park YE; Park KH; Lee CH; Kim CM; Kim DS J Neurol Sci; 2006 Dec; 251(1-2):113-7. PubMed ID: 17092519 [TBL] [Abstract][Full Text] [Related]
23. Blood-based diagnostic testing for Pompe disease: consistency between GAA enzyme activity in dried blood spots and GAA gene sequencing results. Goldstein JL; Dickerson G; Kishnani PS; Rehder C; Bali DS Muscle Nerve; 2014 May; 49(5):775-6. PubMed ID: 24338800 [No Abstract] [Full Text] [Related]
24. Two novel mutations in the gene that codes for acid α-glucosidase in a baby with Pompe disease. Hu J; Sun L; Ren W; Xu M Eur Heart J; 2015 Apr; 36(14):883. PubMed ID: 25612604 [No Abstract] [Full Text] [Related]
25. First clinical and genetic description of a family diagnosed with late-onset Pompe disease from Costa Rica. Torrealba-Acosta G; Rodríguez-Roblero MC; Bogantes-Ledezma S; Carazo-Céspedes K; Desnuelle C Neuromuscul Disord; 2017 Oct; 27(10):951-955. PubMed ID: 28694071 [TBL] [Abstract][Full Text] [Related]
26. Novel GAA sequence variant c.1211 A>G reduces enzyme activity but not protein expression in infantile and adult onset Pompe disease. Nilsson MI; Kroos MA; Reuser AJ; Hatcher E; Akhtar M; McCready ME; Tarnopolsky MA Gene; 2014 Mar; 537(1):41-5. PubMed ID: 24384324 [TBL] [Abstract][Full Text] [Related]
27. Update of the Pompe disease mutation database with 107 sequence variants and a format for severity rating. Kroos M; Pomponio RJ; van Vliet L; Palmer RE; Phipps M; Van der Helm R; Halley D; Reuser A; Hum Mutat; 2008 Jun; 29(6):E13-26. PubMed ID: 18425781 [TBL] [Abstract][Full Text] [Related]
28. Glycogen stored in skeletal but not in cardiac muscle in acid alpha-glucosidase mutant (Pompe) mice is highly resistant to transgene-encoded human enzyme. Raben N; Jatkar T; Lee A; Lu N; Dwivedi S; Nagaraju K; Plotz PH Mol Ther; 2002 Nov; 6(5):601-8. PubMed ID: 12409258 [TBL] [Abstract][Full Text] [Related]
29. Glycogen storage disease type II in Spanish patients: high frequency of c.1076-1G>C mutation. Gort L; Coll MJ; Chabás A Mol Genet Metab; 2007; 92(1-2):183-7. PubMed ID: 17616415 [TBL] [Abstract][Full Text] [Related]
32. Pompe disease presenting as an isolated generalized dilative arteriopathy with repeated brain and kidney infarcts. Quenardelle V; Bataillard M; Bazin D; Lannes B; Wolff V; Echaniz-Laguna A J Neurol; 2015 Feb; 262(2):473-5. PubMed ID: 25451853 [No Abstract] [Full Text] [Related]
33. Thrombotic complications of a basilar artery aneurysm in a young adult with Pompe disease. Refai D; Lev R; Cross DT; Shimony JS; Leonard JR Surg Neurol; 2008 Nov; 70(5):518-20. PubMed ID: 18207222 [TBL] [Abstract][Full Text] [Related]
34. Update of the pompe disease mutation database with 60 novel GAA sequence variants and additional studies on the functional effect of 34 previously reported variants. Kroos M; Hoogeveen-Westerveld M; Michelakakis H; Pomponio R; Van der Ploeg A; Halley D; Reuser A; Hum Mutat; 2012 Aug; 33(8):1161-5. PubMed ID: 22644586 [TBL] [Abstract][Full Text] [Related]
35. Molecular and functional characterization of eight novel GAA mutations in Italian infants with Pompe disease. Pittis MG; Donnarumma M; Montalvo AL; Dominissini S; Kroos M; Rosano C; Stroppiano M; Bianco MG; Donati MA; Parenti G; D'Amico A; Ciana G; Di Rocco M; Reuser A; Bembi B; Filocamo M Hum Mutat; 2008 Jun; 29(6):E27-36. PubMed ID: 18429042 [TBL] [Abstract][Full Text] [Related]
37. Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoter. Sun B; Zhang H; Franco LM; Brown T; Bird A; Schneider A; Koeberl DD Mol Ther; 2005 Jun; 11(6):889-98. PubMed ID: 15922959 [TBL] [Abstract][Full Text] [Related]
38. Broad variation in phenotypes for common GAA genotypes in Pompe disease. Niño MY; In't Groen SLM; de Faria DOS; Hoogeveen-Westerveld M; van den Hout HJMP; van der Ploeg AT; Bergsma AJ; Pijnappel WWMP Hum Mutat; 2021 Nov; 42(11):1461-1472. PubMed ID: 34405923 [TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of aberrant GAA pre-mRNA splicing in pompe disease using a generic approach. Bergsma AJ; Kroos M; Hoogeveen-Westerveld M; Halley D; van der Ploeg AT; Pijnappel WW Hum Mutat; 2015 Jan; 36(1):57-68. PubMed ID: 25243733 [TBL] [Abstract][Full Text] [Related]
40. Generation of induced pluripotent stem cells (iPSCs) from an infant with Pompe disease carrying with compound mutations of R608X and E888X in GAA gene. Zhang Y; Li A; Wang J; Wang G; Wang D Stem Cell Res; 2019 Dec; 41():101621. PubMed ID: 31743840 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]